Product Information
LY 215840 is a cyclase inhibitor that blocks the conversion of 5-hydroxytryptamine (5-HT) to serotonin, which is the final step in the synthesis of this neurotransmitter. LY 215840 has been shown to have glomerulosa activity and can be used in the treatment of thyroid disease and piperazine. LY 215840 also has atypical properties and can be used for the treatment of depression and anxiety disorders. It also has antagonistic effects on 5-ht4 receptors, which leads to an increase in serotonin levels in cells. LY 215840 also has an antagonist effect on melanocortin receptors, which leads to decreased appetite and weight loss.
Chemical properties
Technical inquiry about: 3D-MFA32852 LY 215840
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
